Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Allurion Technologies, Inc. Common Stock (NY:ALUR)

1.750 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	273,757
Open	1.750
Bid (Size)	1.730 (300)
Ask (Size)	1.740 (500)
Prev. Close	1.750
Today's Range	1.750 - 1.750
52wk Range	0.9500 - 4.180
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Did Allurion Stock Surge Over 50% Today? ↗

February 23, 2026

The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule.

Via Stocktwits

Allurion Receives U.S. FDA Approval

February 23, 2026

From Allurion Technologies, Inc.

Via Business Wire

Performance

YTD	+20.7%	+20.7%
1 Month	+25.0%	+25.0%
3 Month	+54.9%	+54.9%
6 Month	-21.9%	-21.9%
1 Year	-48.2%	-48.2%

More News

Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices

February 03, 2026

From Allurion Technologies, Inc.

Via Business Wire

Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results

January 12, 2026

From Allurion Technologies, Inc.

Via Business Wire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Preview: Allurion Technologies's Earnings ↗

August 12, 2025

Via Benzinga

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

November 25, 2025

From Allurion Technologies, Inc.

Via Business Wire

New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone

November 20, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

November 18, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

November 12, 2025

From Allurion Technologies, Inc.

Via Business Wire

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

November 11, 2025

Via Benzinga

A Look at Allurion Technologies's Upcoming Earnings Report ↗

November 11, 2025

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing

November 11, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025

November 06, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss

October 07, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

September 30, 2025

From Allurion Technologies, Inc.

Via Business Wire

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

August 20, 2025

Via Benzinga

Allurion Revenue Drops 71 Percent in Q2 ↗

August 13, 2025

Via The Motley Fool

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

August 13, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025

August 07, 2025

From Allurion Technologies, Inc.

Via Business Wire

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

August 05, 2025

From Allurion Technologies, Inc.

Via Business Wire

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

July 22, 2025

From Allurion Technologies, Inc.

Via Business Wire

Frequently Asked Questions

Is Allurion Technologies, Inc. Common Stock publicly traded?

Yes, Allurion Technologies, Inc. Common Stock is publicly traded.

What exchange does Allurion Technologies, Inc. Common Stock trade on?

Allurion Technologies, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Allurion Technologies, Inc. Common Stock?

The ticker symbol for Allurion Technologies, Inc. Common Stock is ALUR on the New York Stock Exchange

What is the current price of Allurion Technologies, Inc. Common Stock?

The current price of Allurion Technologies, Inc. Common Stock is 1.750

When was Allurion Technologies, Inc. Common Stock last traded?

The last trade of Allurion Technologies, Inc. Common Stock was at 02/23/26 07:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.